CRPGF (China Resources Pharmaceutical Group) Construction In Progress: $427 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRPGF China Resources Pharmaceutical Group Ltd CRPGF
92 GF Score
Price $0.56
GF Value $0.74
! 3 Warning Signs
View Full Analysis

What is China Resources Pharmaceutical Group Construction In Progress?

China Resources Pharmaceutical Group CRPGF 92 Construction In Progress is $427 Mil as of Dec. 2025. GuruFocus rates CRPGF with a GF Score™ of 92/100 and a GF Value™ of $0.74. The stock has 3 warning signs investors should review.

China Resources Pharmaceutical Group's quarterly construction in progress declined from Dec. 2024 ($273 Mil) to Jun. 2025 ($0 Mil) but then increased from Jun. 2025 ($0 Mil) to Dec. 2025 ($427 Mil).

China Resources Pharmaceutical Group's annual construction in progress increased from Dec. 2023 ($241 Mil) to Dec. 2024 ($273 Mil) and increased from Dec. 2024 ($273 Mil) to Dec. 2025 ($427 Mil).

China Resources Pharmaceutical Group Construction In Progress Historical Data

* Premium members only.

The historical data trend for China Resources Pharmaceutical Group's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Pharmaceutical Group Construction In Progress Chart

China Resources Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 155.23 340.22 241.28 273.00 426.78

China Resources Pharmaceutical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 241.28 0.00 273.00 0.00 426.78
CRPGF
92GF Score
China Resources Pharmaceutical Group Ltd CRPGF
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Resources Pharmaceutical Group Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $427 Mil mean?
China Resources Pharmaceutical Group (CRPGF) has a Construction In Progress of $427 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on China Resources Pharmaceutical Group and its competitors.
Is China Resources Pharmaceutical Group's Construction In Progress too high?
China Resources Pharmaceutical Group's current Construction In Progress is $427 Mil. Overall, China Resources Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Pharmaceutical Group's Construction In Progress compare to ZTS and UTHR?
China Resources Pharmaceutical Group's Construction In Progress of $427 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on China Resources Pharmaceutical Group and its competitors. China Resources Pharmaceutical Group's current Construction In Progress is $427 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Pharmaceutical Group stock overvalued right now?
China Resources Pharmaceutical Group (CRPGF) has a current Construction In Progress of $427 Mil. The stock's GF Value™ is $0.74, compared to a current price of $0.56 — trading 24.3% below its estimated fair value. The current Construction In Progress is $427 Mil. China Resources Pharmaceutical Group's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For China Resources Pharmaceutical Group (CRPGF), the current Construction In Progress is $427 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Resources Pharmaceutical Group (CRPGF) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Pharmaceutical Group stock appears to be undervalued. The current stock price of $0.56 is trading 24.3% below its estimated GF Value™ of $0.74.

Key valuation signals for CRPGF:

  • Construction In Progress: $427 Mil
  • GF Value™: $0.74 vs. price of $0.56 (24.3% below fair value)
  • GF Score™: 92/100 with 3 warning signs

No single metric tells the full story. See the CRPGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Resources Pharmaceutical Group Business Description

Other Exchanges 03320:Hong Kong640:Germany
Address 26 Harbour Road, Room 4104-05, 41st Floor, China Resources Building, Wanchai, HKG
China Resources Pharmaceutical Group Ltd is principally engaged in the manufacture, distribution and retail of pharmaceutical and healthcare products. Specifically, the Group has four reportable segments as follows: Pharmaceutical manufacturing business, Pharmaceutical distribution business, Pharmaceutical retail business , and Other business operations. The company generates majority of its revenue from the Pharmaceutical distribution business.
92GF Score

Get the complete analysis for CRPGF

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$0.74
GF Value